Pharvaris N v (PHVS) Annual Balance Sheets

Annual · GAAP · USD millions
Access PHVS quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Pharvaris N v's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents342.31
Cash & Short-term Investments342.00
Accounts receivable0.00
Trade & Other Current Receivables (IFRS combined total)5.34
Total Current Assets326.68
Equipment/Property/Plant Net0.75
Deferred Tax Assets1.04
Other Assets, Noncurrent9.24
Current Deferred Tax Assets-
Trade And Other Current Receivables-
Other Current Assets-
Current Deferred Tax Assets-
Trade And Other Current Receivables-
Trade And Other Current Receivables4.47
Other Current Assets0.62
Trade And Other Current Receivables3.29
Other Current Assets-
Total Assets353.79
Liabilities
Accounts Payable6.00
Total Current Liabilities6.00
Total Long-term Debt0.00
Other liabilities, Noncurrent33.80
Total Liabilities35.42
Stockholders' Equity
Other Equity303.83
Common Stockholder's Equity303.83
Total Stockholder's Equity318.37
Liabilities & Stockholder's Equity353.79
4 historic quarters locked

Sign in to unlock the full Pharvaris N v balance sheet history.

About Pharvaris N V Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001830487-26-000013

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License